Benchling develops cloud-based software platforms that enable biotechnology teams to design, document, and manage scientific experiments and samples throughout the research and development process. Founded in 2012 and headquartered in San Francisco, the company has established itself as a leading provider of digital infrastructure for life sciences organizations, serving pharmaceutical companies, biotech firms, and research institutions globally. With a current valuation of $6.1 billion, Benchling has demonstrated significant growth by addressing the critical need for standardized data management and collaboration tools in scientific research. The company continues expanding its platform capabilities to accelerate biotechnology innovation and drug discovery processes.